Dennis Podlesak - Net Worth and Insider Trading
Dennis Podlesak Net Worth
The estimated net worth of Dennis Podlesak is at least $1 Million dollars as of 2024-09-30. Dennis Podlesak is the Director of Syndax Pharmaceuticals Inc and owns about 75,763 shares of Syndax Pharmaceuticals Inc (SNDX) stock worth over $1 Million. Details can be seen in Dennis Podlesak's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dennis Podlesak has not made any transactions after 2022-09-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dennis Podlesak
Dennis Podlesak Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dennis Podlesak owns 3 companies in total, including Syndax Pharmaceuticals Inc (SNDX) , Adynxx Inc (ADYX) , and Regado Biosciences Inc (RGDO) .
Click here to see the complete history of Dennis Podlesak’s form 4 insider trades.
Insider Ownership Summary of Dennis Podlesak
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2022-09-16 | director |
| ADYX | Adynxx Inc | 2019-05-03 | director |
| RGDO | Regado Biosciences Inc | 2016-11-01 | director |
Dennis Podlesak Latest Holdings Summary
Dennis Podlesak currently owns a total of 1 stock. Dennis Podlesak owns 75,763 shares of Syndax Pharmaceuticals Inc (SNDX) as of September 16, 2022, with a value of $1 Million.
Latest Holdings of Dennis Podlesak
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SNDX | Syndax Pharmaceuticals Inc | 2022-09-16 | 75,763 | 18.89 | 1,431,163 |
Holding Weightings of Dennis Podlesak
Dennis Podlesak Form 4 Trading Tracker
According to the SEC Form 4 filings, Dennis Podlesak has made a total of 2 transactions in Syndax Pharmaceuticals Inc (SNDX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Syndax Pharmaceuticals Inc is the sale of 78,815 shares on September 16, 2022, which brought Dennis Podlesak around $2 Million.
Insider Trading History of Dennis Podlesak
- 1
Dennis Podlesak Trading Performance
GuruFocus tracks the stock performance after each of Dennis Podlesak's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dennis Podlesak is 3.59%. GuruFocus also compares Dennis Podlesak's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dennis Podlesak within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dennis Podlesak's insider trading performs compared to the benchmark.
Performance of Dennis Podlesak
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 24.38 | | | | | |
| Relative Return to S&P 500(%) | 23.88 | | | | | |
Dennis Podlesak Ownership Network
Dennis Podlesak Owned Company Details
What does Syndax Pharmaceuticals Inc do?
Who are the key executives at Syndax Pharmaceuticals Inc?
Dennis Podlesak is the director of Syndax Pharmaceuticals Inc. Other key executives at Syndax Pharmaceuticals Inc include Chief Financial Officer Keith A. Goldan , director & Chief Executive Officer Briggs Morrison , and President & Head of R&D Neil Gallagher .
Syndax Pharmaceuticals Inc (SNDX) Insider Trades Summary
Over the past 18 months, Dennis Podlesak made no insider transaction in Syndax Pharmaceuticals Inc (SNDX). Other recent insider transactions involving Syndax Pharmaceuticals Inc (SNDX) include a net sale of 264,275 shares made by Briggs Morrison , a net purchase of 673 shares made by Keith A. Goldan , and a net sale of 83,000 shares made by William Meury .
In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc (SNDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 347,852 shares of Syndax Pharmaceuticals Inc (SNDX) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 346,602 shares.
Syndax Pharmaceuticals Inc (SNDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syndax Pharmaceuticals Inc Insider Transactions
Dennis Podlesak Mailing Address
Above is the net worth, insider trading, and ownership report for Dennis Podlesak. You might contact Dennis Podlesak via mailing address: C/o Peninsula Pharmaceuticals, Inc., 1751 Harbor Bay Parkway, Alameda Ca 94502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
